BSE Live
Oct 01, 16:01Prev. Close
129.30
Open Price
131.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:57Prev. Close
129.52
Open Price
130.04
Bid Price (Qty.)
132.15 (1117)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 32.45 | 32.45 | 32.45 | 27.19 | 26.21 | |
Total Share Capital | 32.45 | 32.45 | 32.45 | 27.19 | 26.21 | |
Reserves and Surplus | -253.07 | 92.40 | 480.32 | -230.22 | -194.46 | |
Total Reserves and Surplus | -253.07 | 92.40 | 480.32 | -230.22 | -194.46 | |
Total Shareholders Funds | -220.62 | 124.86 | 512.78 | 31.23 | -168.25 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 100.00 | 0.00 | 0.00 | 0.00 | 116.72 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 68.50 | 111.54 | 130.27 | 69.28 | 39.24 | |
Long Term Provisions | 7.68 | 6.05 | 8.14 | 8.15 | 8.63 | |
Total Non-Current Liabilities | 176.17 | 117.59 | 138.41 | 77.43 | 164.59 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 158.19 | 47.00 | 0.05 | 75.00 | 80.00 | |
Trade Payables | 124.40 | 149.82 | 148.25 | 72.19 | 99.06 | |
Other Current Liabilities | 85.40 | 43.52 | 24.15 | 18.96 | 48.54 | |
Short Term Provisions | 5.74 | 3.55 | 6.49 | 5.28 | 5.75 | |
Total Current Liabilities | 373.72 | 243.89 | 178.95 | 171.43 | 233.35 | |
Total Capital And Liabilities | 329.28 | 486.33 | 830.13 | 280.08 | 229.69 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 95.27 | 102.46 | 105.41 | 91.40 | 89.87 | |
Intangible Assets | 0.06 | 0.19 | 0.34 | 0.47 | 0.69 | |
Capital Work-In-Progress | 0.56 | 1.27 | 1.87 | 3.72 | 5.23 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 149.48 | 146.44 | 132.75 | 118.23 | 95.79 | |
Non-Current Investments | 0.42 | 0.42 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | |
Other Non-Current Assets | 154.12 | 93.07 | 242.41 | 90.70 | 70.39 | |
Total Non-Current Assets | 304.02 | 239.93 | 375.16 | 208.93 | 166.58 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 1.80 | 290.90 | 11.66 | 6.43 | |
Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Receivables | 16.06 | 15.53 | 32.71 | 27.74 | 17.58 | |
Cash And Cash Equivalents | 1.19 | 155.06 | 111.58 | 1.23 | 9.31 | |
Short Term Loans And Advances | 0.16 | 0.22 | 0.54 | 0.33 | 0.07 | |
OtherCurrentAssets | 7.85 | 73.79 | 19.23 | 30.19 | 29.73 | |
Total Current Assets | 25.26 | 246.41 | 454.96 | 71.15 | 63.11 | |
Total Assets | 329.28 | 486.33 | 830.13 | 280.08 | 229.69 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 407.82 | 422.56 | 345.46 | 167.13 | 95.28 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 234.95 | 332.37 | 266.21 | 271.20 | 214.14 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 1.68 | 0.64 | 131.72 | 5.02 | 12.00 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 0.42 | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | 290.90 | 11.66 | 6.43 |
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y